A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy

Name: A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Published: 2022
License: Public Domain

Capricor Inc. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

cell-therapy duchenne-muscular-dystrophy genetic-diseases

muscular dystrophies, muscular dystrophy, duchenne, muscular disorders, atrophic, muscular diseases, neuromuscular diseases, genetic diseases, x-linked, genetic diseases, inborn, nervous system diseases, duchenne muscular dystrophy, cell therapy, performance of the upper limb, ambulatory

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 967795
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.